Mainz Return On Equity from 2010 to 2024

MYNZ Stock  USD 7.32  0.40  5.78%   
Mainz Biomed Return On Equity yearly trend continues to be fairly stable with very little volatility. Return On Equity is likely to outpace its year average in 2024. Return On Equity is a measure of the profitability of Mainz Biomed BV in relation to the equity, calculated by dividing net income by shareholder's equity. View All Fundamentals
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
(8.09)
Current Value
(7.69)
Quarterly Volatility
2.97433006
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mainz Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mainz Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 1.1 M or Interest Expense of 419.9 K, as well as many indicators such as Price To Sales Ratio of 19.99, Dividend Yield of 0.0 or PTB Ratio of 6.09. Mainz financial statements analysis is a perfect complement when working with Mainz Biomed Valuation or Volatility modules.
  
Check out the analysis of Mainz Biomed Correlation against competitors.

Latest Mainz Biomed's Return On Equity Growth Pattern

Below is the plot of the Return On Equity of Mainz Biomed BV over the last few years. Return on Equity is the amount of Mainz Biomed BV net income returned as a percentage of Mainz Biomed equity. Return on equity measures Mainz Biomed profitability by revealing how much profit Mainz Biomed BV generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Mainz Biomed's Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mainz Biomed's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported -43.3410 Years Trend
Slightly volatile
   Return On Equity   
       Timeline  

Mainz Return On Equity Regression Statistics

Arithmetic Mean(0.88)
Geometric Mean0.95
Coefficient Of Variation(337.72)
Mean Deviation2.14
Median0.60
Standard Deviation2.97
Sample Variance8.85
Range8.6953
R-Value(0.72)
Mean Square Error4.63
R-Squared0.51
Significance0
Slope(0.48)
Total Sum of Squares123.85

Mainz Return On Equity History

2024 -7.69
2023 -8.09
2022 -1.88
2021 -1.9
2020 0.32

About Mainz Biomed Financial Statements

Mainz Biomed investors use historical fundamental indicators, such as Mainz Biomed's Return On Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mainz Biomed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Equity(8.09)(7.69)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.